Physicochemical characteristics and in vitro release from oil-based vehicles of peptidomimetics: parenteral depots for intra-articular administration

References

• Burton PS, Conradi RA, Ho NFH, Hilgers AR, Borchardt R. (1996). How structural features influence the biomembrane permeability of peptides. J Pharm Sci, 85:1336–40.
   PubMed Web of Science ®Google Scholar
• Steffansen B, Nielsen CU, Frokjaer S. (2005). Delivery aspects of small peptides and substrates for peptide transporters. Eur J Pharm Biopharm, 60:241–5.
   PubMed Web of Science ®Google Scholar
• Bundgaard H. (1992). Means to enhance penetration. (1) Prodrugs as a means to improve the delivery of peptide drugs. Adv Drug Deliv Rev, 8:1–38.
   Web of Science ®Google Scholar
• Gangwar S, Pauletti GM, Wang B, Siahaan TJ, Stella VJ, Borchardt R. (1997). Prodrug strategies to enhance the intestinal absorption of peptides. Drug Discov Today, 2:148–55.
   Web of Science ®Google Scholar
• Oliyai R. (1996). Prodrugs of peptides and peptidomimetics for improved formulation and delivery. Adv Drug Deliv Rev, 19:275–86.
   Web of Science ®Google Scholar
• Burton PS, Conradi RA, Hilgers AR, Ho NFH, Maggiora LL. (1992). The relationship between peptide structure and transport across epithelial cell monolayers. J Control Release, 19:87–98.
   Google Scholar
• Conradi RA, Hilgers AR, Ho NFH, Burton PS. (1991). The influence of peptide structure on transport across Caco-2 cells. Pharm Res, 8:1453–60.
   PubMed Web of Science ®Google Scholar
• Conradi RA, Hilgers AR, Ho NFH, Burton PS. (1992). The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm Res, 9:435–9.
   PubMed Web of Science ®Google Scholar
• Goodwin JT, Conradi RA, Ho NFH, Burton PS. (2001). Physicochemical determinants of passive membrane permeability: Role of solute hydrogen-bonding potential and volume. J Med Chem, 44:3721–9.
   PubMed Web of Science ®Google Scholar
• Sudoh M, Pauletti GM, Yao W, Moser W, Yokoyama A, Pasternak A, . (1998). Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers. Pharm Res, 15:719–25.
   PubMed Web of Science ®Google Scholar
• Holland TA, Mikos AG. (2003). Advances in drug delivery for articular cartilage. J Control Release, 86:1–14.
   PubMed Web of Science ®Google Scholar
• Larsen C, Østergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, . (2008). Intra-articular depot principles: Role in the management of postoperative pain and arthritic disorders. J Pharm Sci, 97:4622–54.
   PubMed Web of Science ®Google Scholar
• Kang F, Singh J. (2005). In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm, 304:83–90.
   PubMed Web of Science ®Google Scholar
• Luan X, Bodmeier R. (2006). In situ forming microparticle system for controlled delivery of leuprolide acetate: Influence of the formulation and processing parameters. Eur J Pharm Sci, 27:143–9.
   PubMed Web of Science ®Google Scholar
• Packhaeuser CB, Schnieders J, Oster CG, Kissel T. (2004). In situ forming parenteral drug delivery systems: An overview. Eur J Pharm Biopharm, 58:445–55.
   PubMed Web of Science ®Google Scholar
• Pauletti GM, Okumu FW, Borchardt RT. (1997). Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res, 14:164–8.
   PubMed Web of Science ®Google Scholar
• Pedersen BT, Østergaard J, Larsen SW, Larsen C. (2005). Characterization of the rotating dialysis cell as an in vitro model potentially useful for simulation of the pharmacokinetic fate of intra-articularly administered drugs. Eur J Pharm Sci, 25:73–9.
   PubMed Web of Science ®Google Scholar
• Ishihama Y, Oda Y, Asakawa N. (1994). Microscale determination of dissolution constants of multivariant pharmaceuticals by capillary electrophoresis. J Pharm Sci, 83:1500–7.
   PubMed Web of Science ®Google Scholar
• Østergaard J, Hansen SH, Larsen C, Schou C, Heegaard NHH. (2003). Determination of octanol-water partition coefficients for carbonate esters and other small organic molecules by microemulsion electrokinetic chromatography. Electrophoresis, 24:1038–46.
   PubMed Web of Science ®Google Scholar
• Kok WT. (2000). Thermal management. Joule heating in CE. Chromatogr Suppl, 51:S24–7.
   Google Scholar
• Dibbern HW, Wirbitzki E. (1983). Possibilities for determining the active substance release from hydrophobic carriers especially as suppositories. Pharm Ind, 45:985–90.
   Web of Science ®Google Scholar
• Schultz K, Møllgaard B, Frokjaer S, Larsen C. (1997). Rotating dialysis cell as in vitro release method for oily parenteral depot solutions. Int J Pharm, 157:163–9.
   PubMed Web of Science ®Google Scholar
• Jackman LM, Sternhell S. (1969). Applications of nuclear magnetic resonance spectroscopy in organic chemistry. 2nd ed. Oxford: Pergamon Press, 94ff.
   Google Scholar
• Larsen DB, Fredholt K, Larsen C. (2001). Addition of hydrogen bond donating excipients to oil solutions: Effect on in vitro drug release rate and viscosity. Eur J Pharm Sci, 13:403–10.
   PubMed Web of Science ®Google Scholar
• Jain N, Yalkowsky SH. (2001). Estimation of the aqueous solubility I: Application to organic nonelectrolytes. J Pharm Sci, 90:234–52.
   PubMed Web of Science ®Google Scholar
• Larsen SW, Frost AB, Østergaard J, Marcher H, Larsen C. (2008). On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds. Eur J Pharm Sci, 34:37–44.
   PubMed Web of Science ®Google Scholar
• Larsen SW, Ankersen M, Larsen C. (2004). Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe). Eur J Pharm Sci, 22:399–408.
   PubMed Web of Science ®Google Scholar
• Goolcharran C, Borchardt RT. (1998). Kinetics of diketopiperazine formation using model peptides. J Pharm Sci, 87:283–8.
   PubMed Web of Science ®Google Scholar
• Østergaard J, Larsen SW, Parshad H, Larsen C. (2005). Bupivacaine salts of diflunisal and other aromatic hydroxycarboxylic acids: Aqueous solubility and release characteristics from solutions and suspensions using a rotating dialysis cell model. Eur J Pharm Sci, 26:280–7.
   PubMed Web of Science ®Google Scholar
• Larsen SW, Østergaard J, Friberg-Johansen H, Jessen MN, Larsen C. (2006). In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration. Eur J Pharm Sci, 29:348–54.
   PubMed Web of Science ®Google Scholar
• Larsen SW, Jessen MNB, Østergaard J, Larsen C. (2008). Assessment of drug release from oil depot formulations using an in vitro model – potential applicability in accelerated release testing. Drug Dev Ind Pharm, 34:297–304.
   PubMed Web of Science ®Google Scholar
• Yunker MH, Borodkin S. (1971). Determination of rate constants for in vitro three-compartment transfer using a two-phase system. J Pharm Sci, 60:52–6.
   PubMed Web of Science ®Google Scholar
• Caldwell JR. (1996). Intra-articular corticosteroids. Drugs, 52:507–14.
   PubMed Web of Science ®Google Scholar
• Yu LX, Foster TP, Sarver RW, Moseley WM. (1996). Preparation, characterization, and in vivo evaluation of an oil suspension of bovine growth hormone releasing factor analog. J Pharm Sci, 85:396–401.
   PubMed Web of Science ®Google Scholar
• Pedersen BT, Larsen SW, Østergaard J, Larsen C. (2008). In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed, and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration. Drug Deliv, 15:23–30.
   PubMed Web of Science ®Google Scholar
• Larsen C, Larsen SW, Østergaard J, Pedersen BT. (2003). Drug-containing vehicles for local administrations of active drug substances. PA/DK 2003 01748.
   Google Scholar